Simon "Niels" Groen and coauthor Sophie Zaaijer published an article in Human Genomics regarding melanin reducing the effect of certain drugs. The work advocates that researchers include more diversity in genetic backgrounds  for pharmaceutical development, especially when creating computer models or conducting clinical trials.